Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03098004 · ClinicalTrials.gov registry record · NA
Effects of e-Cigarettes on Nicotine Withdrawal
A NA study of Electronic Cigarettes, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03098004: Completed NA study of Electronic Cigarettes, sponsored by University of Southern California.
NCT03098004 is a NA study of Electronic Cigarettes that has completed, run by University of Southern California. The registered enrollment target is 37 participants, roughly in line with the 37-participant average among 3 other Electronic Cigarettes trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03098004, a NA study of Electronic Cigarettes, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This behavioral pharmacology laboratory experiment will assess whether sweet (vs. non-sweet) flavored e-cigarette solutions reduce tobacco withdrawal symptoms and motivation to smoke among 40 smokers interested in trying e-cigarettes (for the first time) following 16-hours of nicotine abstinence. The study's experimental design will provide evidence of the causal effects of e-cigarette flavorings on a putatively critical factor for determining whether smokers continue e-cigarette use after initial trial-the ability of a product to suppress withdrawal and motivation to smoke during periods of tobacco deprivation.
Primary Outcome
The 10-item Positive Affect Negative Affect Schedule (PANAS-SF) will be used to measure positive and negative affect.
Conditions Studied
Interventions
- OTHER e-Cigarette
Study Locations (1)
California
- USC Health, Emotion and Addiction Laboratory - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
What the finished NCT03098004 record still lists
NCT03098004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, roughly in line with the 37-participant average among 3 other Electronic Cigarettes trials with a reported enrollment target.
The record links to 1 condition, with Electronic Cigarettes appearing as the primary indexed condition, and to 1 intervention - of which e-Cigarette is the first listed.
NCT03098004 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03098004 about?
NCT03098004 is a clinical study titled "Effects of e-Cigarettes on Nicotine Withdrawal". This behavioral pharmacology laboratory experiment will assess whether sweet (vs. non-sweet) flavored e-cigarette solutions reduce tobacco withdrawal symptoms and motivation to smoke among 40 smokers interested in trying e-cigarettes (for the first time) following 16-hours of nicotine abstinence. Th...
What is the current status of trial NCT03098004?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-01-01. Estimated completion is 2019-08-31.
What conditions does trial NCT03098004 study?
This clinical trial studies the following conditions: Electronic Cigarettes.
What interventions are being tested in trial NCT03098004?
The interventions under investigation include: e-Cigarette (OTHER).
Who is sponsoring clinical trial NCT03098004?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03098004 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarettes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI